Patents by Inventor Malcolm B. Perry

Malcolm B. Perry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5006463
    Abstract: A method is disclosed for discriminating between cattle vaccinated against and those infected with Brucella spp. The method involves immunoassay using a purified polysaccharide containing 4,6-dideoxy-4-acylamido-D-mannopyranosyl units obtained from B. abortus or from cross-reacting organisms, and results in improved differentiation between vaccinated and infected animals. Test kits are also disclosed for performing the assay and a process is disclosed for obtaining the O-chain polysaccharides in high purity and yield.
    Type: Grant
    Filed: September 25, 1987
    Date of Patent: April 9, 1991
    Assignee: National Research Council of Canada
    Inventors: John W. Cherwonogrodzky, J. Robert Duncan, Klaus Nielsen, Peter F. Wright, David R. Bundle, Malcolm B. Perry
  • Patent number: 4831126
    Abstract: The antigenic O-chain polysaccharides from Brucella abortus and Yersinia enterocolitica serotype 0:9 have similar structure, i.e. 1-2 linked 4,6-dideoxy-4-formamido-.alpha.-D-mannopyranosyl units. The antigen is more readily isolated from the Yersinia and may be chemically modified to have a hydrophobic moiety attached thereto. The antigen can be adsorbed or coupled to carriers suitable for immunoassay use such as ELISA and RIA. A monoclonal antibody capable of specifically binding to B. abortus and Y. enterocolitica, has been produced. Assay procedures and kits therefor, are described.
    Type: Grant
    Filed: February 26, 1985
    Date of Patent: May 16, 1989
    Assignee: Canadian Patents & Development Ltd.
    Inventors: David R. Bundle, Malcolm B. Perry, John W. Cherwonogrodzky, J. Robert Duncan, Martine G. Caroff
  • Patent number: 4755459
    Abstract: Monoclonal antibodies specific to Neisseria gonorrhoeae lipopolysaccharide components having no cross-reactivity with N. meningitidis have been produced and found useful in the diagnosis of the presence of N. gonorrhoeae.
    Type: Grant
    Filed: June 10, 1985
    Date of Patent: July 5, 1988
    Assignee: Canadian Patents and Development Limited
    Inventors: Terry W. Pearson, Malcolm B. Perry
  • Patent number: 4115543
    Abstract: A reagent and test for the identification of the bacterium Neisseria gonorrhoeae. Lipopolysaccharide antigen, found to be common to N. gonorrhoeae strains, is used to inoculate fowl, and serum from the fowl recovered containing antibodies causing agglutination of cells of all N. gonorrhoeae strains. The identification test comprises adding the recovered antibody reagent to a suspension of bacterial cells, the occurrence of cell agglutination being a positive test for N. gonorrhoeae.
    Type: Grant
    Filed: December 20, 1976
    Date of Patent: September 19, 1978
    Assignee: Canadian Patents & Development Limited
    Inventors: Rebecca Wallace, Fraser E. Ashton, Malcolm B. Perry, Benito B. Diena